Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Dialysis
Hyperphosphatemia

Interventions

DRUG: MCI-196

Sponsor

Tanabe Pharma Corporation